FDA.reportPublic FDA data

Allergy Eye Relief

Product NDC
59262-354
Requested package NDC
59262-354-01
11-digit product format
592620354
Labeler code
59262
Product ID
59262-354_4fb82880-2d17-48ad-aa2d-cdbacdff7348
Type
HUMAN OTC DRUG
Nonproprietary name
Apis and Euphrasia and Sabadilla
Dosage form
SOLUTION/ DROPS
Route
OPHTHALMIC
Labeler
Similasan Corporation
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start
2013-07-02
Marketing end
0000-00-00
Substance
APIS MELLIFERA; EUPHRASIA STRICTA; SCHOENOCAULON OFFICINALE SEED
Active strength
6 [hp_X]/.4mL; [hp_X]/.4mL; [hp_X]/.4mL
NDC exclude flag
No
Listing certified through
2021-12-31
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage59262-35459262-354-01IInactivated by FDA2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 15 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Snapshot, Source SHA-256 table
Captured / source dateSnapshotSource SHA-256
2025-12-14 17:58 UTC · source 2025-12-05d630ba8d3edf…732f749b63fb…
2025-08-27 00:01 UTC · source 2025-08-26f5e01cc5f278…a2eaf40c39c3…
2025-04-01 02:39 UTC · source 2025-03-312ef7874e63bc…57b86245f4fa…
2025-03-28 20:22 UTC · source 2025-03-28a1b67e2a42f9…c4cf2c586c0d…
2025-03-22 03:12 UTC · source 2025-03-21cfe11265f3b6…090c488252e2…
2025-03-10 12:48 UTC · source 2025-03-10cdf11ea48f46…ba0047e9e063…
2025-02-02 03:52 UTC · source 2025-01-31302b2466d912…e7b80fea0513…
2025-01-20 13:05 UTC · source 2025-01-20ed331223b511…672a5bd82f5f…
2025-01-11 03:41 UTC · source 2025-01-100efc9e666f02…f202fb6c5f17…
2024-11-09 02:27 UTC · source 2024-11-08ad56d346431e…cc804d4bbf1e…
2024-10-04 04:10 UTC · source 2024-10-03367a005e9d99…383a685ebd0f…
2024-07-10 04:00 UTC · source 2024-07-09557ba5c1ecfa…9c80585c8c6e…
2024-05-28 21:12 UTC · source 2024-05-288af77b9d5b6f…d9bbb34c5368…
2024-05-15 03:39 UTC · source 2024-05-14834df4deac94…adcc014656a3…
2024-03-11 06:39 UTC · source 2024-03-081332a3947898…d4bfe170f9cd…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
726062af-1135-4707-a1d7-57256991bbf9Product name220250226
19c71a3d-ed9c-166b-a7e5-38c250c35631Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
59262-354-012023-01-30C16284748780-1f386c64a-13a5-0266-e053-dadaa90a7c1aAllergy Eye Relief Trial Size
59262-354-132023-01-30C16284748780-1f386c64a-13a5-0266-e053-dadaa90a7c1aAllergy Eye Relief Trial Size

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
59262-354-01Allergy Eye Relief0.4 mL in 1 VIAL, SINGLE-USESOLUTION/ DROPS0.47
59262-354-01Allergy Eye Relief200 in 1 CARTONSOLUTION/ DROPS2007
59262-354-13Allergy Eye Relief.4 mL in 1 VIAL, SINGLE-USESOLUTION/ DROPS.47

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
APIS MELLIFERAACTIVE INGREDIENT7S82P3R43ZALLERGY EYE RELIEF (APIS AND EUPHRASIA AND SABADILLA) SOLUTION/ DROPS [SIMILASAN CORPORATION]4
EUPHRASIA STRICTAACTIVE INGREDIENTC9642I91WLALLERGY EYE RELIEF (APIS AND EUPHRASIA AND SABADILLA) SOLUTION/ DROPS [SIMILASAN CORPORATION]4
SCHOENOCAULON OFFICINALE SEEDACTIVE INGREDIENT6NAF1689IOALLERGY EYE RELIEF (APIS AND EUPHRASIA AND SABADILLA) SOLUTION/ DROPS [SIMILASAN CORPORATION]4
APIS MELLIFERAACTIVE MOIETY7S82P3R43ZALLERGY EYE RELIEF (APIS AND EUPHRASIA AND SABADILLA) SOLUTION/ DROPS [SIMILASAN CORPORATION]4
EUPHRASIA STRICTAACTIVE MOIETYC9642I91WLALLERGY EYE RELIEF (APIS AND EUPHRASIA AND SABADILLA) SOLUTION/ DROPS [SIMILASAN CORPORATION]4
SCHOENOCAULON OFFICINALE SEEDACTIVE MOIETY6NAF1689IOALLERGY EYE RELIEF (APIS AND EUPHRASIA AND SABADILLA) SOLUTION/ DROPS [SIMILASAN CORPORATION]4
SODIUM PHOSPHATE, DIBASIC, ANHYDROUSINACTIVE INGREDIENT22ADO53M6FALLERGY EYE RELIEF (APIS AND EUPHRASIA AND SABADILLA) SOLUTION/ DROPS [SIMILASAN CORPORATION]4
SODIUM PHOSPHATE, MONOBASIC, DIHYDRATEINACTIVE INGREDIENT5QWK665956ALLERGY EYE RELIEF (APIS AND EUPHRASIA AND SABADILLA) SOLUTION/ DROPS [SIMILASAN CORPORATION]4
WATERINACTIVE INGREDIENT059QF0KO0RALLERGY EYE RELIEF (APIS AND EUPHRASIA AND SABADILLA) SOLUTION/ DROPS [SIMILASAN CORPORATION]4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
59262-354ALLERGY EYE RELIEF (APIS AND EUPHRASIA AND SABADILLA) SOLUTION/ DROPS [SIMILASAN CORPORATION]7Legacy NDC, 3 package rows20200709_3f0ddebd-7d36-43cb-ba40-45998546a7a7.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
59262-354-0159262035401200 VIAL, SINGLE-USE in 1 CARTON (59262-354-01) > .4 mL in 1 VIAL, SINGLE-USE2013-07-020000-00-00NoNoCurrent